Literature DB >> 15452382

Raynaud's phenomenon and endothelial dysfunction in end-stage renal disease patients treated with hemodialysis.

Aneta Czupryniak1, Anna Kałuzyńska, Michał Nowicki, Bogusław Wiecek, Edward Bald, Danuta Owczarek.   

Abstract

BACKGROUND/AIMS: Steal syndrome is a well-known complication of arteriovenous shunt placement. Increased frequency of Raynaud's phenomenon (RP) especially concerning shunt limb is reported among hemodialysis (HD) patients. The aim of the study was to assess the relation of impairment of peripheral circulation diagnosed with cold stress test (CST) and thermography to the AV shunt location and markers of endothelial dysfunction in HD patients.
METHODS: The study group comprised 21 patients (6 male, 15 female, mean age 32.6 +/- 15.0 years) treated with HD for a mean of 69 +/- 54 months. 10 healthy individuals (4 male, 6 female, mean age 38.6 +/- 14.7 years) served as controls. The diagnosis of RP was made upon the results of thermographic measurements during CST. Von Willebrand factor activity and antigen, endothelin-1 and plasma total homocysteine (tHcy) were measured in all subjects.
RESULTS: RP was found significantly more often in HD patients than in controls: 11/21 vs. 1/10 (p = 0.04). RP occurred in both hands in 7/11 (64%) patients. tHcy was higher in HD patients than in the controls (31.7 +/- 13.9 vs. 10.9 +/- 3.2 microg/l, p < 0.0001). tHcy and von Willebrand factor antigen were significantly higher in the RP-positive than RP-negative patients or controls.
CONCLUSION: Small vessel dysfunction diagnosed as positive RP is a frequent finding in HD patients. It seems that endothelial injury rather than AV shunt steal syndrome is responsible for development of RP in HD patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452382     DOI: 10.1159/000081059

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  4 in total

Review 1.  Endothelial dysfunction in cardiovascular disease and Flammer syndrome-similarities and differences.

Authors:  Jens Barthelmes; Matthias P Nägele; Valeria Ludovici; Frank Ruschitzka; Isabella Sudano; Andreas J Flammer
Journal:  EPMA J       Date:  2017-06-06       Impact factor: 6.543

2.  Primary Raynaud's phenomenon in an infant: a case report and review of literature.

Authors:  Anjali A Sharathkumar; Paul Castillo-Caro
Journal:  Pediatr Rheumatol Online J       Date:  2011-07-18       Impact factor: 3.054

3.  Cyclosporine A - treated nephrotic children show impaired vasodilatation but no autonomic neuropathy.

Authors:  Aneta Czupryniak; Anna Kałużyńska; Anna Półtorak-Krawczyk; Bartosz Ostrowski; Bogusław Więcek; Marcin Tkaczyk
Journal:  Arch Med Sci       Date:  2010-09-07       Impact factor: 3.318

4.  Plasma Homocysteine is Not Related to the Severity of Microangiopathy in Secondary Raynaud Phenomenon.

Authors:  Vincenzo Jacomella; Monika Wasila; Marc Husmann; Gabriela Gitzelmann; Thomas Meier; Beatrice Amann-Vesti
Journal:  Open Rheumatol J       Date:  2011-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.